Dr. Reddy’s Laboratories Ltd. trading as Dr. Reddy’s, founded in 1984 by Dr. K. Anji Reddy, has become India’s biggest pharmaceutical company. Dr. Anji Reddy had worked in the publicly-owned Indian Drugs and Pharmaceuticals Ltd. Reddy’s manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has more than 190 medications ready for patients to take, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care and biotechnology products.

Dr. Reddy’s began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets – that had the advantage of not having to spend time and money on a manufacturing plant that that would gain approval from a drug licensing body such as the US’s Food and Drug Administration. Much of Reddy’s early success came in those unregulated markets, where process patents – not product patents – are recognized. With that money in the bank, the company could reverse-engineer patented drugs from more developed countries and sell them royalty-free in India and Russia. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.

The company has a presence across the value chain, producing and delivering safe, innovative, and high quality finished dosage forms, active pharmaceutical ingredients and biological products, which are marketed to over 100 countries including US, Europe, Russia, Asia Pacific, India and China.

The Company conducts NCE drug discovery research in the areas of metabolic disorders, cardiovascular indications and infectious diseases. Its drug discovery effort is carried out at its research facilities in Atlanta, USA, and in Hyderabad, India.

By 2007, Dr. Reddy’s had six FDA-plants producing active pharmaceutical ingredients in India and seven FDA-inspected and ISO 9001 (quality) and ISO 14001 (environmental management) certified plants making patient-ready medications – five of them in India and two in the UK.

The company top 10 brands in the India market are:

Omez
Nise
Stamlo
Stamlo Beta
Enam
Atocor
Razo
Reclimet
Clamp
Mintop

Corporate Office:

Dr. Reddy’s Laboratories Ltd.
8-2-337, Road No 3,
Banjara Hills,
Hyderabad – 500034,
India

Tel: +91-40-49002900
Fax: +91-40-49002999

List of office

http://www.drreddys.com